In general, this study may contribute to providing a foundation for more understanding the molecular basis of SKA-mediated BC development, thereby providing valuable information on whether SKA1/2/3 could be used as potential tumor-promoting regulators of BC. The gene discussed is SKA1; the disease is breast cancer.